EP4104865 - ANTI-EGFR ANTIBODY DRUG CONJUGATES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 20.10.2023 Database last updated on 29.06.2024 | |
Former | Request for examination was made Status updated on 23.06.2023 | ||
Former | The application has been published Status updated on 18.11.2022 | Most recent event Tooltip | 23.04.2024 | Deletion: Reply to examination report | 23.04.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US | [2022/51] | Inventor(s) | 01 /
BOGHAERT, Erwin R. Pleasant Prairie, 53158 / US | 02 /
SOUERS, Andrew J. Libertyville, 60048 / US | 03 /
PHILLIPS, Andrew C. Libertyville, 60048 / US | 04 /
JUDD, Andrew S. Grayslake, 60030 / US | 05 /
BRUNCKO, Milan Green Oaks, 60048 / US | [2022/51] | Representative(s) | Schlich, George, et al Schlich 9 St Catherine's Road Littlehampton, West Sussex BN17 5HS / GB | [2022/51] | Application number, filing date | 22166591.2 | 07.06.2017 | [2022/51] | Priority number, date | US201662347416P | 08.06.2016 Original published format: US 201662347416 P | [2022/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4104865 | Date: | 21.12.2022 | Language: | EN | [2022/51] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.11.2022 | Classification | IPC: | A61K47/68, C07K16/28, A61K39/395, A61K39/00, A61P35/00, A61P43/00 | [2022/51] | CPC: |
A61K39/39591 (EP,CN,IL,KR);
A61K47/6803 (EP,CN,IL,KR,US);
C07K16/2863 (EP,CN,IL,KR,US);
A61K31/4439 (CN,IL);
A61K31/47 (CN,IL);
A61K31/4985 (CN,IL);
A61K38/04 (CN,IL);
A61K45/06 (CN,IL,US);
A61K47/6849 (EP,CN,IL,KR,US);
A61K47/6889 (EP,IL);
A61P35/00 (EP,CN,IL,KR,US);
A61P43/00 (EP,CN,IL);
A61K2039/505 (EP,IL,KR);
C07K2317/51 (CN,IL);
C07K2317/515 (CN,IL);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/30] |
Former [2022/51] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | ANTI-EGFR-ANTIKÖRPER-WIRKSTOFF-KONJUGATE | [2022/51] | English: | ANTI-EGFR ANTIBODY DRUG CONJUGATES | [2022/51] | French: | CONJUGUÉS DE MÉDICAMENTS-ANTICORPS ANTI-EGFR | [2022/51] | Examination procedure | 21.06.2023 | Amendment by applicant (claims and/or description) | 21.06.2023 | Examination requested [2023/30] | 21.06.2023 | Date on which the examining division has become responsible | 23.10.2023 | Despatch of a communication from the examining division (Time limit: M06) | 23.04.2024 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP17731394.7 / EP3468996 | Fees paid | Renewal fee | 04.04.2022 | Renewal fee patent year 03 | 04.04.2022 | Renewal fee patent year 04 | 04.04.2022 | Renewal fee patent year 05 | 04.04.2022 | Renewal fee patent year 06 | 31.03.2023 | Renewal fee patent year 07 | 31.03.2024 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2013055897 (ABBVIE INC [US]); | [A]WO2015143382 (ABBVIE INC [US]); | [AP]WO2016094505 (ABBVIE INC [US]); | [AP]WO2016094509 (ABBVIE INC [US]); | [AP]WO2016094517 (ABBVIE INC [US]) | by applicant | WO8912624 | WO9005144 | US5124471 | US5286850 | US5434287 | US5624821 | US5648260 | US5714350 | WO9954342 | EP1176195 | US6350861 | US2002137134 | WO03016466 | WO03035835 | US2004018590 | WO2004010957 | WO2005100584 | US2005271615 | US2006116422 | US7223837 | US2009318668 | US2010152725 | US7989434 | US2012183471 | US8349308 | US8399512 | US2013224228 | US8524214 | US8535678 | US8568728 | US2013309256 | WO2013173337 | WO2014093379 | WO2014093394 | WO2014093640 | US2015337042 | US9493568 | US2016339117 | US20130189218 | US20140017265 |